Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Seidel, MG; Minkov, M; Witt, V; Matthes-Martin, S; Pötschger, U; Worel, N; Leitner, G; Stary, J; Gadner, H; Peters, C.
Granulocyte transfusions in children and young adults: does the dose matter?
J Pediatr Hematol Oncol. 2009; 31(3):166-172
Doi: 10.1097/MPH.0b013e318196a6f9
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Seidel Markus
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background: Granulocyte transfusions (GTs) may increase the absolute neutrophil count (ANC) before hematopoietic regeneration in neutropenic patients after chemotherapy or hematopoietic stem cell transplantation and Support anti-infective immunity. Procedure: We assessed efficacy and tolerability of 778 GTs in 70 treatment episodes of 49 children and 10 Young adults [median age 6.28 y (range: 0.13 to 17.7 y) and 21 y (18.0 to 28.0), respectively] suffering from bacterial (n = 55) and/or fungal (n = 31) infections during neutropenia owing to conventional chemotherapy (n = 14), hematopoietic stein cell transplantation conditioning (it 44), or the underlying disease (n = 1). We analyzed the impact of body weight. organ dysfunction, neutrophil close on ANC increment. infection elimination, and survival. Results: The median day-5 ANC increment was 1460/mu L, correlating to the administered close. However, 28-day survival did not correlate to the neutrophil dose nor to the ANC increment., potentially owing to the high number of neutrophils transfused to all patients (median > 6 x 10(9)/kg within 5d). The 28-day survival probability of the total patient cohort was 0.72 +/- 0.06 and the 100-day survival was 0.52 +/- 0.07. Adverse reactions were rare including fever (<= World Health Organization grade 111. 14%), chills (3%), and mild pulmonary complications (1%). Conclusions: These data corroborate the empirical evidence that GT with sufficient cell doses and rapid availability are a feasible, well-tolerated supplemental means to fight severe infections in neutropenic patients.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Bacterial Infections - mortality Bacterial Infections - therapy
- Child -
- Child, Preschool -
- Female -
- Granulocytes - transplantation
- Humans -
- Infant -
- Kaplan-Meier Estimate -
- Leukocyte Transfusion - adverse effects Leukocyte Transfusion - methods
- Male -
- Neutropenia - mortality Neutropenia - therapy
- Virus Diseases - mortality Virus Diseases - therapy
- Young Adult -
- Find related publications in this database (Keywords)
- febrile neutropenia
- invasive aspergillosis
- granulocyte transfusions
- infectious complications
- stem cell transplantation
- high-dose chemotherapy